CHI3L1 and glioblastoma: Despite little discrepancy in CHI3L1′s ability to distinguish GBM patient groups from healthy controls, this protein demonstrated a reliable (p = 0.02) difference (Figure 2A) in patient overall survival based on the median CHI3L1 value.